Related Experiment Video

Updated: Jul 3, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death

Mark Wade1, Luo Wei Rodewald, Joaquín M Espinosa

  • 1Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California 92037, USA.

Cell Cycle (Georgetown, Tex.)
|July 8, 2008
PubMed

Insights

High Hdmx protein levels in tumors limit p53 activity and apoptosis. Combining Hdm2 antagonists with Bcl-2 family member antagonists effectively restores apoptosis in cancer cells by activating Bax.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • The Hdmx protein inhibits p53 activity and is overexpressed in human tumors with wild-type p53.
  • Understanding Hdmx's role in limiting p53 activation and apoptosis is crucial for developing new cancer therapies.

Purpose of the Study:

  • To investigate the role of Hdmx in tumor cell sensitivity to Hdm2 antagonists.
  • To identify therapeutic strategies to overcome Hdmx-mediated resistance to apoptosis.

Main Methods:

  • Assessed tumor cell sensitivity to Hdm2 antagonists (Nutlin-3a and MI-219) in the presence of varying Hdmx levels.
  • Evaluated the efficacy of combined treatment with Hdm2 antagonists and Bcl-2 family member antagonists.
  • Investigated the mechanism of apoptosis induction upstream of Bax activation.

Main Results:

  • Hdmx overexpression hinders the efficacy of Hdm2 antagonists as single agents by preventing the disruption of Hdmx/p53 complexes.
  • Combined treatment with Nutlin and a Bcl-2 family member antagonist restored apoptosis sensitivity in cells with high Hdmx levels.
  • The findings support a model where Hdmx inhibits the intrinsic apoptotic pathway upstream of Bax activation.

Conclusions:

  • Disrupting Hdmx/p53 complexes is essential for effective cancer therapy using Hdm2 antagonists.
  • A combination strategy inhibiting Hdm2 and activating Bax shows promise for inducing apoptosis in Hdmx-high tumors.
  • Targeted drug dosing can achieve preferential apoptosis induction in tumor cells over normal cells.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...